Nonadherence in the Advanced Heart Failure Population

被引：11
作者：
Gandhi J. [1 ]
McCue A. [1 ]
Cole R. [1 ]
机构：
[1] Emory University School of Medicine, Emory University, 1365 Clifton Road NE, Atlanta, 30322, GA
来源：
Current Heart Failure Reports | 2016年 / 13卷 / 2期
关键词：
Heart failure; Heart transplant; Left ventricular assist device; Nonadherence;
D O I：
10.1007/s11897-016-0287-7
中图分类号：
学科分类号：
摘要：
The number of patients living with heart failure (HF) in the USA now exceeds 5 million. Although HF is a disease readily treated by medications and lifestyle interventions, nonadherence is common, leading to worse clinical outcomes and increased healthcare costs. While adherence to medical therapy and clinician recommendations is key in the management of HF, it is perhaps more critical in patients with the most advanced disease, including those receiving home inotropic infusion, heart transplantation, or a left ventricular assist device. Yet, there is a paucity of data on the effects of nonadherence on the advanced heart failure population and little information on the most effective management strategies in these patients. Future studies of nonadherence in HF should utilize uniform definitions of adherence and, ideally, more objective measurements of adherence such as the novel “digital pill” technology. © 2016, Springer Science+Business Media New York.
引用
收藏
页码：77 / 85
页数：8
相关论文
共 42 条
  • [1] Roger V.L., Go A.S., Lloyd-Jones D.M., Benjamin E.J., Berry J.D., Borden W.B., Heart disease and stroke statistics—2012 update: a report from the American Heart Association, Circulation, 125, pp. e2-e220, (2012)
  • [2] Stevenson L.W., Projecting heart failure into bankruptcy in 2012?, Am Heart J, 161, pp. 1007-1011, (2011)
  • [3] Roger V.L., Weston S.A., Redfield M.M., Hellermann-Homan J.P., Killian J., Yawn B.P., Et al., Trends in heart failure incidence and survival in a community-based population, Jama, 292, pp. 344-350, (2004)
  • [4] Fitzgerald A.A., Powers J.D., Ho P.M., Maddox T.M., Peterson P.N., Allen L.A., Et al., Impact of medication nonadherence on hospitalizations and mortality in heart failure, J Card Fail, 17, pp. 664-669, (2011)
  • [5] Hershberger R.E., Nauman D., Walker T.L., Dutton D., Burgess D., Care processes and clinical outcomes of continuous outpatient support with inotropes (COSI) in patients with refractory endstage heart failure, J Card Fail, 9, pp. 180-187, (2003)
  • [6] Non-compliance. Oxford Press, 2015, Accessed, (2015)
  • [7] A National Action Plan to Address America's “Other Drug Problem, Accelerating progress in prescription medicine adherence: the adherence action agenda, (2013)
  • [8] a systemwide approach to improving patient medication adherence for chronic disease, (2009)
  • [9] Osterberg L., Blaschke T., Adherence to medication, N Engl J Med, 353, pp. 487-497, (2005)
  • [10] Monane M., Bohn R.L., Gurwitz J.H., Glynn R.J., Avorn J., Noncompliance with congestive heart failure therapy in the elderly, Arch Intern Med, 154, pp. 433-437, (1994)
12345